ME Therapeutics Holdings Management
Management criteria checks 0/4
ME Therapeutics Holdings' CEO is Salim Dhanji, appointed in Mar 2023, has a tenure of 1.67 years. directly owns 17.67% of the company’s shares, worth €10.04M. The average tenure of the management team and the board of directors is 1.7 years and 1.7 years respectively.
Key information
Salim Dhanji
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.7yrs |
| CEO ownership | 17.7% |
| Management average tenure | 1.7yrs |
| Board average tenure | 1.7yrs |
Recent management updates
Recent updates
CEO
Salim Dhanji
1.7yrs
Tenure
Dr. Salim Dhanji is Chief Executive Officer and Director of ME Therapeutics Holdings Inc. from March 9, 2023. He serves as Head of Pre-Clinical Research at Qu Biologics Inc. Dr. Dhanji has done extensive p...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.7yrs | no data | 17.67% € 10.0m | |
| Chief Financial Officer | 1.7yrs | €32.62k | no data | |
| Corporate Secretary | 1.7yrs | no data | no data | |
| Chief Business Officer | less than a year | no data | no data |
1.7yrs
Average Tenure
Experienced Management: Q9T's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.7yrs | no data | 17.67% € 10.0m | |
| Director | 1.7yrs | no data | 17.64% € 10.0m | |
| Director | 1.4yrs | no data | no data | |
| Director | 1.7yrs | no data | 17.67% € 10.0m |
1.7yrs
Average Tenure
Experienced Board: Q9T's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.